Venous thromboembolic disease.

Published

Journal Article

Venous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the occurrence of VTE in patients with cancer who are considered at high risk for developing this complication. Therefore, it is critical to recognize the various risk factors for VTE in patients with cancer. Risk assessment tools are available to help identify patients for whom discussions regarding the potential benefits and risks of thromboprophylaxis would be appropriate. The NCCN Clinical Practice Guidelines in Oncology for VTE provide recommendations on risk evaluation, diagnosis, prevention, and treatment of VTE in patients with cancer.

Full Text

Duke Authors

Cited Authors

  • Streiff, MB; Bockenstedt, PL; Cataland, SR; Chesney, C; Eby, C; Fanikos, J; Fogerty, AE; Gao, S; Goldhaber, SZ; Hassoun, H; Hendrie, P; Holmstrom, B; Kuderer, N; Lee, JT; Millenson, MM; Neff, AT; Ortel, TL; Siddiqi, T; Smith, JL; Yee, GC; Zakarija, A; McMillian, N; Naganuma, M; National comprehensive cancer network,

Published Date

  • November 2013

Published In

Volume / Issue

  • 11 / 11

Start / End Page

  • 1402 - 1429

PubMed ID

  • 24225973

Pubmed Central ID

  • 24225973

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0163

Language

  • eng

Conference Location

  • United States